8-1923017-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_014629.4(ARHGEF10):​c.2197C>T​(p.His733Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.00175 in 1,613,580 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H733R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0012 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0018 ( 4 hom. )

Consequence

ARHGEF10
NM_014629.4 missense

Scores

1
6
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 4.39

Publications

4 publications found
Variant links:
Genes affected
ARHGEF10 (HGNC:14103): (Rho guanine nucleotide exchange factor 10) This gene encodes a Rho guanine nucleotide exchange factor (GEF). Rho GEFs regulate the activity of small Rho GTPases by stimulating the exchange of guanine diphosphate (GDP) for guanine triphosphate (GTP) and may play a role in neural morphogenesis. Mutations in this gene are associated with slowed nerve conduction velocity (SNCV). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]
ARHGEF10 Gene-Disease associations (from GenCC):
  • autosomal dominant slowed nerve conduction velocity
    Inheritance: Unknown, AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
  • hereditary peripheral neuropathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • peripheral neuropathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.02310282).
BP6
Variant 8-1923017-C-T is Benign according to our data. Variant chr8-1923017-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 157538.
BS2
High AC in GnomAd4 at 178 Unknown,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARHGEF10NM_014629.4 linkc.2197C>T p.His733Tyr missense_variant Exon 19 of 29 ENST00000349830.8 NP_055444.2 O15013-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARHGEF10ENST00000349830.8 linkc.2197C>T p.His733Tyr missense_variant Exon 19 of 29 1 NM_014629.4 ENSP00000340297.3 O15013-5
KBTBD11-OT1ENST00000635855.1 linkn.*2151C>T non_coding_transcript_exon_variant Exon 20 of 30 5 ENSP00000489726.1 A0A1B0GTJ5
KBTBD11-OT1ENST00000635855.1 linkn.*2151C>T 3_prime_UTR_variant Exon 20 of 30 5 ENSP00000489726.1 A0A1B0GTJ5

Frequencies

GnomAD3 genomes
AF:
0.00117
AC:
178
AN:
152092
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000314
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00222
Gnomad OTH
AF:
0.000480
GnomAD2 exomes
AF:
0.00107
AC:
268
AN:
251168
AF XY:
0.000994
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000463
Gnomad ASJ exome
AF:
0.000992
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000140
Gnomad NFE exome
AF:
0.00191
Gnomad OTH exome
AF:
0.000816
GnomAD4 exome
AF:
0.00181
AC:
2642
AN:
1461372
Hom.:
4
Cov.:
31
AF XY:
0.00176
AC XY:
1282
AN XY:
726996
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33468
American (AMR)
AF:
0.000514
AC:
23
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00119
AC:
31
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39650
South Asian (SAS)
AF:
0.000568
AC:
49
AN:
86226
European-Finnish (FIN)
AF:
0.000395
AC:
21
AN:
53224
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5694
European-Non Finnish (NFE)
AF:
0.00217
AC:
2415
AN:
1111890
Other (OTH)
AF:
0.00159
AC:
96
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.440
Heterozygous variant carriers
0
134
268
403
537
671
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00117
AC:
178
AN:
152208
Hom.:
1
Cov.:
33
AF XY:
0.000900
AC XY:
67
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.000313
AC:
13
AN:
41536
American (AMR)
AF:
0.000392
AC:
6
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.000283
AC:
3
AN:
10594
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00222
AC:
151
AN:
68018
Other (OTH)
AF:
0.000475
AC:
1
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
9
17
26
34
43
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00162
Hom.:
3
Bravo
AF:
0.00121
TwinsUK
AF:
0.00324
AC:
12
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00163
AC:
14
ExAC
AF:
0.00108
AC:
131
Asia WGS
AF:
0.000578
AC:
2
AN:
3476
EpiCase
AF:
0.00142
EpiControl
AF:
0.00148

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Jan 14, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 24, 2022
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ARHGEF10: BS1, BS2 -

Charcot-Marie-Tooth disease Uncertain:1
Nov 01, 2013
Dept. of Medical Genetics, Telemark Hospital Trust, Telemark Hospital Trust
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

- -

Autosomal dominant slowed nerve conduction velocity Uncertain:1
Oct 02, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.31
.;.;.;T;.
Eigen
Uncertain
0.20
Eigen_PC
Benign
0.12
FATHMM_MKL
Uncertain
0.96
D
M_CAP
Benign
0.060
D
MetaRNN
Benign
0.023
T;T;T;T;T
MetaSVM
Benign
-0.42
T
MutationAssessor
Uncertain
2.7
.;.;.;M;.
PhyloP100
4.4
PrimateAI
Uncertain
0.67
T
PROVEAN
Pathogenic
-4.7
D;D;D;D;D
REVEL
Uncertain
0.36
Sift
Benign
0.13
T;T;T;T;T
Sift4G
Benign
0.11
T;T;T;T;T
Polyphen
0.83
P;D;.;D;.
Vest4
0.43
MVP
0.74
MPC
0.052
ClinPred
0.20
T
GERP RS
4.0
Varity_R
0.24
gMVP
0.62
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147531758; hg19: chr8-1871183; API